All Programs
Popular
Steve Jackson, PharmD
Alexander Spira, MD, PhD, FACP
- NEW EPISODEMinuteCE®
ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
0.50 program creditsAditya Bardia, MD, MPH, FASCO
- NEW EPISODEMinuteCE®
SERENA-6: Acting on ESR1 Mutations in Advanced Breast Cancer
0.50 program creditsErica L. Mayer, MD, MPH
Aditya Bardia, MD, MPH, FASCO
Erica L. Mayer, MD, MPH
- Oncology and Hematology
DESTINY-Breast05 Findings Lead to New Indication for Trastuzumab Deruxtecan as Adjuvant Treatment for Residual Invasive Disease
Sara A. Hurvitz, MD, FACP
Charles Turck, PharmD, BCPS, BCCCP
Rohit Thummalapalli, MD
- Oncology and Hematology
TROPION-Breast02: Evidence for the Approval of Datopotamab Deruxtecan for Patients With mTNBC Ineligible for Immunotherapy
Tiffany Traina, MD, FASCO
Charles Turck, PharmD, BCPS, BCCCP
Rohit Thummalapalli, MD
Roberto Leon-Ferre, MD
Jennifer Johnson, MD, PhD
Roberto Leon-Ferre, MD
Roberto Leon-Ferre, MD
Charles Turck, PharmD, BCPS, BCCCP
Stephanie Gregory, CNP
Charles Turck, PharmD, BCPS, BCCCP
Alexander Spira, MD, PhD, FACP
Robert Merritt, MD
Charles Turck, PharmD, BCPS, BCCCP
Melina Marmarelis, MD
Deepa Rangachari, MD
Charles Turck, PharmD, BCPS, BCCCP
Paul Bunn, MD
